HK1198512A1 - An inhalable medicament comprising tiotropium - Google Patents

An inhalable medicament comprising tiotropium

Info

Publication number
HK1198512A1
HK1198512A1 HK14111996.5A HK14111996A HK1198512A1 HK 1198512 A1 HK1198512 A1 HK 1198512A1 HK 14111996 A HK14111996 A HK 14111996A HK 1198512 A1 HK1198512 A1 HK 1198512A1
Authority
HK
Hong Kong
Prior art keywords
tiotropium
inhalable medicament
inhalable
medicament
Prior art date
Application number
HK14111996.5A
Other languages
English (en)
Chinese (zh)
Inventor
Xian-Ming Zeng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45813952&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1198512(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of HK1198512A1 publication Critical patent/HK1198512A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK14111996.5A 2011-12-19 2014-11-27 An inhalable medicament comprising tiotropium HK1198512A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161577315P 2011-12-19 2011-12-19
GBGB1200525.2A GB201200525D0 (en) 2011-12-19 2012-01-13 An inhalable medicament
PCT/EP2012/074690 WO2013092237A1 (en) 2011-12-19 2012-12-06 An inhalable medicament comprising tiotropium

Publications (1)

Publication Number Publication Date
HK1198512A1 true HK1198512A1 (en) 2015-05-15

Family

ID=45813952

Family Applications (2)

Application Number Title Priority Date Filing Date
HK14111996.5A HK1198512A1 (en) 2011-12-19 2014-11-27 An inhalable medicament comprising tiotropium
HK15100893.1A HK1200343A1 (en) 2011-12-19 2015-01-27 An inhalable medicament comprising tiotropium

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15100893.1A HK1200343A1 (en) 2011-12-19 2015-01-27 An inhalable medicament comprising tiotropium

Country Status (29)

Country Link
US (1) US9655969B2 (es)
EP (3) EP2793886B1 (es)
JP (1) JP5791166B2 (es)
KR (2) KR20160111539A (es)
CN (1) CN103998039A (es)
AR (1) AR089302A1 (es)
AU (1) AU2012358475B2 (es)
BR (1) BR112014014535A2 (es)
CA (1) CA2856047C (es)
CY (1) CY1116142T1 (es)
DK (3) DK3143998T3 (es)
EA (1) EA028461B1 (es)
ES (3) ES2728940T3 (es)
GB (1) GB201200525D0 (es)
HK (2) HK1198512A1 (es)
HR (1) HRP20141176T1 (es)
HU (2) HUE030983T2 (es)
IL (1) IL232946A0 (es)
MX (1) MX361925B (es)
PL (3) PL2793886T3 (es)
PT (1) PT2606891E (es)
RS (1) RS53783B1 (es)
SI (1) SI2606891T1 (es)
SM (1) SMT201400192B (es)
TR (1) TR201908429T4 (es)
TW (1) TWI468187B (es)
UY (1) UY34525A (es)
WO (1) WO2013092237A1 (es)
ZA (2) ZA201403041B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG181870A1 (en) 2009-12-23 2012-07-30 Chiesi Farma Spa Aerosol formulation for copd
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
AU2014352793B2 (en) * 2013-11-22 2019-05-09 Teva Branded Pharmaceutical Products R&D, Inc. An inhalable medicament
CA2930173A1 (en) 2013-11-22 2015-05-28 Teva Branded Pharmaceutical Products R&D, Inc. An inhalable medicament
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US20190054010A1 (en) * 2015-10-29 2019-02-21 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
ES2956521T3 (es) * 2016-09-19 2023-12-22 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende bromuro de tiotropio
WO2020006017A1 (en) * 2018-06-27 2020-01-02 3M Innovative Properties Company Tiotropium formulation and inhaler

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB9026191D0 (en) * 1990-12-01 1991-01-16 Harris Pharma Ltd Breath actuated dispensing device
ATE128350T1 (de) 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
GB2264238A (en) 1992-05-29 1993-08-25 Norton Healthcare Ltd Medicament inhalor device
AU680227B2 (en) 1992-12-09 1997-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US6309671B1 (en) 1995-04-14 2001-10-30 Inhale Therapeutic Systems Stable glassy state powder formulations
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
CA2347856C (en) 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
JP4691298B2 (ja) 1999-10-12 2011-06-01 科研製薬株式会社 粉末吸入用製剤及びその製造方法
US20060257324A1 (en) 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
DZ3358A1 (fr) 2000-05-22 2001-11-29 Chiesi Farma Spa Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
US6553988B1 (en) 2000-06-09 2003-04-29 Norton Healthcare, Inc. Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
AU2002214996B2 (en) 2000-10-12 2007-03-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
AU757008B2 (en) 2000-10-12 2003-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel tiotropium-containing inhalation powder
PT1243263E (pt) * 2001-03-21 2003-03-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma
DE10126924A1 (de) 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
US20030070679A1 (en) 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
NZ530690A (en) 2001-06-22 2005-05-27 Boehringer Ingelheim Pharma Crystalline anticholinergic, proccesses for preparing it and its use for preparing a pharmaceuticaal composition
DE10130371A1 (de) 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
US20040126325A1 (en) * 2002-03-12 2004-07-01 David Lewis Medicinal aerosol solution formulation products with improved chemical stability
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
DE10214263A1 (de) 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
GB0219511D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
PL375868A1 (en) * 2002-12-16 2005-12-12 Boehringer Ingelheim Pharma Gmbh & Co.Kg Tiotropium containing hfc solution formulations
US20050058606A1 (en) 2002-12-16 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing HFC solution formulations
DE10339197A1 (de) 2003-08-22 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
US20070189979A1 (en) 2003-09-18 2007-08-16 Norton Healthcare Limited T/A Ivax Pharmaceuticals Particles
US7968717B2 (en) 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
CN100509809C (zh) 2003-11-03 2009-07-08 贝林格尔·英格海姆国际有限公司 具有抗胆碱能作用的新颖无水晶体
SE0303570L (sv) 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
JP2007528409A (ja) 2004-03-09 2007-10-11 アリバ ファーマシューティカルズ, インコーポレイテッド プロテアーゼインヒビターの低用量吸入による慢性閉塞性肺疾患の処置
US20060079544A1 (en) 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
BRPI0607990A2 (pt) * 2005-02-25 2009-10-27 Chiesi Farma Spa formulação de um aerossol farmacêutico para inaladores dosimetrados pressurizados contendo um agente seqüestrante, uso do agente sequestrante, inalador de dosimetrado pressurizado e método de preenchimento do inalador de aerossol
WO2006117299A2 (en) 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
EP1879888A2 (en) 2005-05-02 2008-01-23 Boehringer Ingelheim International GmbH Crystalline forms of tiotropium bromide
NZ564697A (en) 2005-06-15 2010-04-30 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
RU2422144C2 (ru) 2005-08-06 2011-06-27 Бёрингер Ингельхайм Интернациональ Гмбх Применение солей тиотропия для лечения тяжелых форм персистирующей астмы
US20070088030A1 (en) 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
US8163913B2 (en) 2005-12-19 2012-04-24 Sicor Inc. Forms of tiotropium bromide and processes for preparation thereof
EP1923393A1 (en) 2006-11-17 2008-05-21 Boehringer Ingelheim Pharma GmbH & Co. KG Crystalline form of tiotropium bromide and urea
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
EP2201934A1 (en) 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
CN102292072A (zh) 2009-01-26 2011-12-21 特瓦制药工业有限公司 用微粒包衣载体的方法
CA2781012A1 (en) * 2009-11-17 2011-05-26 Cipla Limited Inhalation solutions
KR101559639B1 (ko) 2010-10-12 2015-10-12 아이박스 파마슈티컬즈 아일랜드 비강 분무 장치
GB201200504D0 (en) 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung

Also Published As

Publication number Publication date
SI2606891T1 (sl) 2015-04-30
AU2012358475A8 (en) 2014-06-26
AU2012358475A1 (en) 2014-05-22
EA028461B1 (ru) 2017-11-30
PL2793886T3 (pl) 2017-06-30
GB201200525D0 (en) 2012-02-29
TR201908429T4 (tr) 2019-07-22
ES2728940T3 (es) 2019-10-29
CA2856047A1 (en) 2013-06-27
HK1200343A1 (en) 2015-08-07
DK3143998T3 (da) 2019-06-17
IL232946A0 (en) 2014-07-31
DK2793886T3 (en) 2016-12-05
TWI468187B (zh) 2015-01-11
NZ624161A (en) 2015-08-28
JP5791166B2 (ja) 2015-10-07
UY34525A (es) 2014-07-31
HUE030983T2 (en) 2017-06-28
RS53783B1 (en) 2015-06-30
AU2012358475B2 (en) 2015-08-20
JP2015500224A (ja) 2015-01-05
EP2606891B1 (en) 2014-11-05
US9655969B2 (en) 2017-05-23
BR112014014535A2 (pt) 2017-06-13
PL2606891T3 (pl) 2015-07-31
EP3143998A1 (en) 2017-03-22
AR089302A1 (es) 2014-08-13
EP2606891A1 (en) 2013-06-26
CA2856047C (en) 2017-01-03
DK2606891T3 (en) 2015-01-05
ZA201501986B (en) 2016-10-26
US20140348758A1 (en) 2014-11-27
CN103998039A (zh) 2014-08-20
TW201332587A (zh) 2013-08-16
ES2602314T3 (es) 2017-02-20
KR101670564B1 (ko) 2016-10-28
KR20140097481A (ko) 2014-08-06
CY1116142T1 (el) 2017-03-15
SMT201400192B (it) 2015-03-05
EP2793886B1 (en) 2016-08-24
PL3143998T3 (pl) 2019-09-30
WO2013092237A1 (en) 2013-06-27
KR20160111539A (ko) 2016-09-26
MX361925B (es) 2018-12-19
ZA201403041B (en) 2015-11-25
PT2606891E (pt) 2015-01-05
HRP20141176T1 (hr) 2015-03-13
EA201491206A1 (ru) 2014-12-30
ES2526685T3 (es) 2015-01-14
EP2793886A1 (en) 2014-10-29
EP3143998B1 (en) 2019-05-22
HUE044647T2 (hu) 2019-11-28
MX2014007357A (es) 2014-08-21

Similar Documents

Publication Publication Date Title
IL232768A0 (en) A drug delivery device
HK1191522A1 (zh) 吸入器組件
HK1189463A1 (zh) 吸入器組件
ZA201307378B (en) Medicament delivery device
AU342595S (en) Inhaler device
HK1198435A1 (en) Inhaler
IL227712A0 (en) Device for sending medicine
HUE040353T2 (hu) Inhalátorból és kapszulából álló rendszer
PL2865403T3 (pl) Inhalator
ZA201501986B (en) An inhalable medicament comprising tiotropium
GB2490770B (en) Drug delivery inhaler devices
GB201200504D0 (en) An inhaler
HK1198692A1 (en) Inhaler
EP2788053A4 (en) DEVICE FOR DELIVERING MEDICAMENTS
HK1206292A1 (en) Medicament administration
EP2687212A4 (en) DRUG AGENT
HK1200390A1 (en) Inhalable microemulsion comprising anaesthetic
AU343374S (en) Inhaler
GB201121693D0 (en) Medicament delivery technology
AU342044S (en) Inhaler
AU342091S (en) Inhaler
AU342045S (en) Inhaler
AU342046S (en) Inhaler
AU344082S (en) Inhaler
AU344099S (en) Inhaler